NCT07587892

Brief Summary

This prospective single-center randomized clinical trial evaluates whether the use of argon plasma coagulation (APC) during open excisional hemorrhoidectomy reduces postoperative pain and perioperative morbidity compared with conventional monopolar coagulation in adults with symptomatic grade III-IV hemorrhoids requiring surgical treatment. A total of 100 participants will be randomized in a 1:1 ratio to open hemorrhoidectomy performed with APC or open hemorrhoidectomy performed with monopolar coagulation. In two arms, the severity of pain will be assessed from day 1 to day 7 postoperatively, both before and after taking analgesics. Additional assessments will be conducted on days 14 and 28 post-surgery, as well as during the first and second defecation using a visual analog scale (VAS). Early postoperative complications, including intraoperative and postoperative bleeding, burning sensation and itching will be evaluated. Long-term complications such as anal canal stenosis, perianal scar deformation, and disease recurrence will be assessed six months after surgery using digital examination performed by consultant proctologist. The goal of this clinical trial is to discover the safety and efficacy of open excisional hemorrhoidectomy for hemorrhoids III-IV grade using argon plasma coagulation.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Aug 2023Oct 2026

Study Start

First participant enrolled

August 1, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 5, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 14, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

2.6 years

First QC Date

April 5, 2026

Last Update Submit

May 14, 2026

Conditions

Keywords

HemorrhoidsHemorrhoidectomyArgon plasma coagulationGrade III hemorrhoidsGrade IV hemorrhoidsPostoperative painProctology

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity before taking analgesics on postoperative day 4

    Postoperative pain intensity will be assessed using the visual analog scale (VAS; 0 = no pain, 10 = worst imaginable pain). The primary analysis will compare the VAS pain scores on postoperative day 4, before taking analgesics;

    Assessment on the fourth postoperative day

Secondary Outcomes (14)

  • Postoperative pain intensity on day 14

    Assessment on the postoperative day 14

  • Postoperative pain intensity after the first defecation

    At the day of the first defecation during first week after surgery

  • Intraoperative bleeding

    During surgery

  • Postoperative bleeding

    From surgery through postoperative day 28

  • Rate of Participants with postoperative burning sensation and itching

    From surgery through postoperative day 28

  • +9 more secondary outcomes

Study Arms (2)

argon plasma coagulation- APC-arm

EXPERIMENTAL

A total of 100 participants will be randomized in a 1:1 ratio to open hemorrhoidectomy performed with APC or open hemorrhoidectomy performed with monopolar coagulation. In APC arm will be 50 participants.Patients aged ≥18 years with symptomatic grade III -IV hemorrhoids refractory to conservative treatment will eligible for inclusion. Exclusion criteria are: * external hemorrhoids thrombosis * patients with grade I-II hemorrhoids * acute and chronic anal fissures * requiring combined interventions * previous surgical interventions for hemorrhoids like a rubber band ligation * sclerotherapy or laser hemorrhoidplasty (LHP) * pregnancy * Any known anorectal malignancy or suspicion of malignancy * Significant systemic diseases (severe cardiovascular disease, severe hepatic dysfunction)

Procedure: open hemorrhoidectomy using argon plasma coagulation

open hemorrhoidectomy using monopolar coagulation

ACTIVE COMPARATOR

In MC arm will be 50 participants

Procedure: open hemorrhoidectomy using momopolar coagulation

Interventions

After spinal anesthesia and positioning in lithotomy, the external component of the hemorrhoidal cushion will be grasped with Allis forceps, followed by its traction medially. Using argon plasma coagulation at the "cut" mode (power - 40W), an initial incision will be made in the peri-anal skin above the external hemorrhoidal node. Then, using "argon plasma coagulation" mode (power - 40W), the internal and external hemorrhoidal components will undergo dissection from the sphincters down to the vascular pedicle with preservation of mucocutaneous bridges. The vascular pedicle will be coagulated using the APC and cut. The tips of the surgery include non-suturing approach to vascular pedicle and non-touch technique to the preserved tissue for reducing pain severity. APC may allow to perform bloodless surgery due to welding of vessels.

argon plasma coagulation- APC-arm

In the MC arm, participants will undergo the same open excisional hemorrhoidectomy technique, but tissue dissection and hemostasis will be performed using standard monopolar coagulation according to institutional routine practice

open hemorrhoidectomy using monopolar coagulation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • external hemorrhoids thrombosis
  • patients with grade I-II hemorrhoids
  • acute and chronic anal fissures
  • requiring combined interventions
  • previous surgical interventions for hemorrhoids like a rubber band ligation
  • sclerotherapy or laser hemorrhoidplasty (LHP)
  • pregnancy
  • Any known anorectal malignancy or suspicion of malignancy
  • Significant systemic diseases (severe cardiovascular disease, severe hepatic dysfunction)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinical Hospital №4, Sechenov University, Moscow, Russia

Moscow, Moscow, 101000, Russia

Location

Related Publications (2)

  • Efetov S, Otabekov A, Koziy A. Seamless open excisional haemorrhoidectomy-Six faces of surgical technique: A Video Vignette. Colorectal Dis. 2024 Jul;26(7):1478-1479. doi: 10.1111/codi.17009. Epub 2024 May 21. No abstract available.

    PMID: 38773684BACKGROUND
  • Efetov S, Rebrova A, Volgin M, Koziy AY, Zubayraeva A. Argon plasma coagulation in two-step procedure for surgical treatment of huge circular four-stage haemorrhoids - A video vignette. Colorectal Dis. 2025 Sep;27(9):e70237. doi: 10.1111/codi.70237. No abstract available.

    PMID: 40990073BACKGROUND

Related Links

MeSH Terms

Conditions

HemorrhoidsPain, Postoperative

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Sergey K Efetov, MD, PhD

    I.M. Sechenov First Moscow State Medical University (Sechenov University)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Efetov Sergey

Study Record Dates

First Submitted

April 5, 2026

First Posted

May 14, 2026

Study Start

August 1, 2023

Primary Completion

March 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

May 18, 2026

Record last verified: 2026-05

Locations